menu
    • menu

    Company profile for Johnson & Johnson

    NEW Drugs in Dev: 150
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talen...
    At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Johnson & JohnsonUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Johnson & Johnson PlazaNew Brunswick, New Jersey 08933
    Telephone
    Telephone
    +1 7325240400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jnj.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/johnson-&-johnson/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/JNJNews

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J Presents Nipocalimab Data Lowering Autoantibodies in Sjögren
    J&J Presents Nipocalimab Data Lowering Autoantibodies in Sjögren

    03 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/johnson--johnson-presents-new-data-further-reinforcing-the-role-of-nipocalimab-in-lowering-the-autoantibodies-driving-sjogrens-disease-302789435.html

    PR NEWSWIRE
    03 Jun 2026
    Share Share
    J&J Late-Breaking Data Show Nipocalimab Reduces SLE Activity
    J&J Late-Breaking Data Show Nipocalimab Reduces SLE Activity

    03 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/johnson--johnson-late-breaking-results-show-nipocalimab-significantly-reduced-systemic-lupus-erythematosus-sle-disease-activity-in-a-phase-2-study-302789438.html

    PR NEWSWIRE
    03 Jun 2026
    Share Share
    Amivantamab FASPRO Shows Strong Responses in Head & Neck Cancer
    Amivantamab FASPRO Shows Strong Responses in Head & Neck Cancer

    31 May 2026

    // PRESS RELEASE

    https://www.jnj.com/media-center/press-releases/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-pivotal-data-show-strong-and-durable-responses-in-advanced-head-and-neck-cancer-where-options-remain-limited

    PRESS RELEASE
    31 May 2026
    Share Share
    J&J Prostate Cancer Drug Cuts Spread and Death Risk
    J&J Prostate Cancer Drug Cuts Spread and Death Risk

    31 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/jj-prostate-cancer-drug-reduces-risk-cancer-spread-death-late-stage-study-2026-05-31/

    REUTERS
    31 May 2026
    Share Share
    Amivantamab + Lazertinib Shows Durable Benefit in EGFR NSCLC
    Amivantamab + Lazertinib Shows Durable Benefit in EGFR NSCLC

    29 May 2026

    // PRESS RELEASE

    https://www.jnj.com/media-center/press-releases/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-demonstrates-prolonged-clinical-benefit-as-a-first-line-treatment-for-atypical-egfr-mutated-non-small-cell-lung-cancer

    PRESS RELEASE
    29 May 2026
    Share Share
    Teclistamab Boosts PFS & OS at First Relapse in Multiple Myeloma
    Teclistamab Boosts PFS & OS at First Relapse in Multiple Myeloma

    29 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-tecvayli-teclistamab-cqyv-data-demonstrate-superior-progression-free-and-overall-survival-as-early-as-first-relapse-in-multiple-myeloma-302785621.html

    PR NEWSWIRE
    29 May 2026
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Johnson & Johnson and get a quotation

    Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find Nicotine bulk with DMF offered by Johnson & Johnson

    Find Naloxone Hydrochloride bulk offered by Johnson & Johnson

    Find Sodium Hyaluronate bulk offered by Johnson & Johnson

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search